Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Details

Autor(en) / Beteiligte
Titel
High-gain polymer optical waveguide amplifiers based on core-shell NaYF4/NaLuF4: Yb3+, Er3+ NPs-PMMA covalent-linking nanocomposites
Ist Teil von
  • Scientific reports, 2016-11, Vol.6 (1), p.36729-36729, Article 36729
Ort / Verlag
London: Nature Publishing Group
Erscheinungsjahr
2016
Link zum Volltext
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Abstract Waveguide amplifiers have always been significant key components for optical communication. Unfortunately, the low concentration of rare earth ions doped in the host material and the inadequate optimization of the waveguide structure have been the common bottleneck limitations. Here, a novel material, NaYF 4 /NaLuF 4 : 20% Yb 3+ , 2% Er 3+ nanoparticle-Polymeric Methyl Methacrylate covalent-linking nanocomposite, was synthesized. The concentrations of Er 3+ and Yb 3+ doping increased an order of magnitude. Under a 980 nm laser excitation, highly efficient emission at 1.53 μm was obtained. The characteristic parameters of the single mode waveguide were carefully designed and optimized by using a finite difference method. A formulized iteration method is presented for solving the rate equations and the propagation equations of the EYCDWA, and both the steady state behavior and the gain were numerically simulated. The optimal Er 3+ and Yb 3+ concentrations are 2.8 × 10 26 m −3 and 2.8 × 10 27 m −3 , and the optimal waveguide length is 1.3 cm. Both theoretical and experimental results indicated that, for an input signal power of 0.1 mW and a pump power of 400 mW, a net gain of 15.1 dB at 1530 nm is demonstrated. This result is the highest gain ever reported in polymer-based waveguide amplifiers doped with inorganic Er 3+ -Yb 3+ codoped nanocrystals.
Sprache
Englisch
Identifikatoren
ISSN: 2045-2322
eISSN: 2045-2322
DOI: 10.1038/srep36729
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5101484

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX